PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

38,655 stories, page 306 of 645

Advanced search
🌍Researchdoi.orgTier 1 · Research record

Think Beyond The Core: Computationally Decoding the Hydrophilic Corona of Drug‐Loaded Polymer Micelles

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Expanded <scp> <i>ATXN10</i> </scp> Alleles in Neurodegenerative Disorders: A Case Series and Review of the Literature

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

When Therapy Goes Online: How Orientation, Experience, and Perceived Patient Openness Shape Attitudes Toward Online Therapy. A Study Based on the Unified Theory of Acceptance and Use of Technology for Therapists During the COVID‐19 Pandemic

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

The Case of an 18‐Year‐Old Female With Persistent Vague Pain in the Top of the Occiput

CrossrefOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Innovent Doses First Patient in Phase 3 Trial of IBI363 for Advanced Colorectal Cancer

BioPharma APACOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Large Trial Finds High-Dose Vitamin D Did Not Slow Metastatic Colorectal Cancer

inklOriginal source
🇺🇸Industrybiomarin.comTier 1 · Company source

Cristin Hubbard Reflects on a Career Spent Bringing Innovation to Patients – and Why Working at BioMarin Has Her More Energized Than Ever

BioMarin PharmaceuticalOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Enterprise value to EBIT forward of CH Biotech R&D Co., Ltd. – TWSE:6534

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Purple Biotech Releases Q2 2026 Financial Results

AlphaStreetOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

BioMarin (BMRN) Stock Gains On Higher Outlook Despite Profit Drop

simplywall.stOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Moleculin Biotech Inc expected to post a loss of $1.54 a share - Earnings Preview

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Machine learning powered protein engineering lab could accelerate biotech innovation

Digital JournalOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FALSE CLAIMS ACT—E.D. Pa.: Pharmacy’s usage of certain ‘Dispense as Written’ (DAW) Codes, not material to government’s decision to pay

VitalLaw.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

MoonLake Stock Soars As Biotech Fund Reloads, Takeover Chatter Ignites

StocktwitsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Eli Lilly: 'Strong Buy' On Retatrutide Obesity Drug And EBGLYSS Maintenance Label Expansion

Seeking AlphaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Psyence BioMed’s Big Bet Is Vertical Psilocybin And Ibogaine Supply

FinimizeOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Enterprise value to EBIT forward of PET Pharm Biotech Co., Ltd. – TPEX:7762

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Braveheart Bio (BRVE) Stock Price, News & Analysis

MarketBeatOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Russian strike damages major pharmaceutical warehouse in Ukraine

International Rescue CommitteeOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Recovery for Replimune: Accelerated Approval for Cancer Drug Twice Spurned by FDA

MedCity NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA Rule for Generic Drug Labels Would Alter Scope for Tort Liability

Law.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

HQH: After Biotech’s Breakout Year, This Healthcare CEF Still Trades Below NAV; Buy

Seeking AlphaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Explainer: Maharashtra shows the way in food safety

The TribuneOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

How to Find and Evaluate Clinical Trials for Metastatic Bladder Cancer

Everyday HealthOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Creative Medical Technology (NASDAQ: CELZ) Q2 loss, cash rises to $8.7M

Stock TitanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Narcolepsy treatment advances with FDA approval for new Takeda drug

Mix ValeOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Collegium Pharmaceutical (COLL) Stock May Trade At A Discount Even After A 60% Return

simplywall.stOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Latigo Biotherapeutics, Clinical-Stage Developer of Selective Nav1.8 Non‑Opioid Pain Medicines for Acute and Chronic Pain, Files for Nasdaq Global Select Market IPO

tradingview.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

AIM ImmunoTech (NYSE: AIM) returns to positive equity after new financings

Stock TitanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

COMPASS Pathways plc (5Y6.F) stock price, news, quote and history

Yahoo Finance SingaporeOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswireOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Something Is Rotten at CMS: Dr. Oz Demands FDA Approval - Then Defends a $500 Medicare Pathway for Unapproved Hemp Products

ACCESS NewswireOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Entera Announces Second Quarter 2026 Financial Results and Business Updates

The Manila TimesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

The Manila TimesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Form 424B3 SOLIGENIX, INC.

streetinsider.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Form 424B3 SOLIGENIX, INC.

StreetInsiderOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA approves Orzeyful, first drug to treat all symptoms of narcolepsy type 1

Managed Healthcare ExecutiveOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

aTyr Pharma Announces Second Quarter 2026 Results, Program Prioritization and Corporate Restructuring to Support Efzofitimod Program in ILD

The Manila TimesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Entera Plans Late-2026 Trial of Oral Osteoporosis Tablet in ~750 Women

Stock TitanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA approves first-in-class drug to treat narcolepsy

drugdiscoverynews.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Nymox Pharmaceutical (NYMXF) schedules August 28 shareholder vote on board

Stock TitanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Biohaven Ltd. (BHVN) stock price, news, quote and history

Yahoo Finance AustraliaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

CASTL and NIBRT team to bring biomanufacturing training to Canada

BioProcess InternationalOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Cooley Leads 2 Biotech Firms Pricing IPOs Totaling $496M

Law360Original source
🌍discoverynews.google.comTier 3 · Aggregated media

Morgan Stanley Issues Positive Forecast for BioMarin Pharmaceutical (NASDAQ:BMRN) Stock Price

MarketBeatOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Two IIT-Bombay hostel canteens closed for operating without licences

India TodayOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Karnataka FDA Finds Expired Food At Bengaluru's Five Star Hotels In Surprise Raid

OneindiaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

UK patients being recruited for ribupatide trials

The Pharmaceutical JournalOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

New platform speeds bacterial gene mapping for better biotech design

Phys.orgOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Could 1 Tiny Biotech Topple Vertex Pharmaceuticals' Cystic Fibrosis Empire?

The Motley FoolOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA Approves Moderna's Next-Generation mRNA Flu Vaccine for Emergency Use.

The Taiwan TimesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

LigaChem Gains Sole Control of B7-H4 Cancer Drug With Distinct Tumor-Killing Mechanism

Tech TimesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

P2.2-M unregistered food seized

tribune.net.phOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Maharashtra FDA issues first statewide blood bank safety order

India TodayOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Amazon Pharmacy to Offer GLP-1 Delivery Service | PharmExec

Pharmaceutical ExecutiveOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

NRx Pharmaceuticals Shares Rise as FDA Completes Initial Review of Ketamine Product

citybizOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

These Two Biotech Stocks Hit Fresh 52-Week Highs Today – NTRA Clocks Best Day In Nearly 20 Months

TradingViewOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Latigo, BlossomHill cap busy week in biotech IPOs with nearly $500M haul

FirstWord PharmaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Japan's Ono Pharmaceutical Funds Fibrosis Discovery After Lilly's $99M Bet on Same Biotech

Tech TimesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Inside Bengaluru’s star hotel kitchens: Officials find expired milk, rotten vegetables

The Times of IndiaOriginal source